Gershuni Victoria M, Bittner James G, Moley Jeffrey F, Brunt L Michael
Department of Surgery, Washington University School of Medicine , St. Louis, Missouri.
J Laparoendosc Adv Surg Tech A. 2014 Jan;24(1):8-12. doi: 10.1089/lap.2013.0411. Epub 2013 Dec 13.
Adrenal myelolipoma (AM) is a benign lesion for which adrenalectomy is infrequently indicated. We investigated operative indications and outcomes for AM in a large single-institution series.
A retrospective cohort study of prospectively collected data was conducted. Patients (≥16 years of age) who underwent adrenalectomy in the Division of General Surgery at Barnes-Jewish Hospital (1993-2010) were grouped by operative indication (myelolipoma versus other pathology) and compared using nonparametric tests (α<0.05).
Sixteen patients (4.0%) had myelolipomas resected out of 402 patients who underwent adrenalectomy. Fourteen patients with suspected AM underwent adrenalectomy, 13 (93%) of whom had AM confirmed on pathology. Indications for adrenalectomy were abdominal or flank pain, large tumor size (>8 cm), atypical radiologic appearance, and/or inferior vena cava compression. Three patients with suspected other adrenal lesions had AM confirmed on final pathology. Operative approach was laparoscopic in 15 cases and open in 1 case of a 21-cm lesion. Patients who underwent laparoscopic adrenalectomy for AM (n=15) or other adrenal pathology (n=343) were similar with respect to age, gender, American Society of Anesthesiologists classification, prior abdominal operation, tumor side, operative time, conversion rate, estimated blood loss, intraoperative complications, hospital length of stay, and 30-day morbidity. However, patients with resected AM had a higher body mass index (36.5±8.1 kg/m(2) versus 30.1±7.5 kg/m(2); P<.01) and a larger preoperative tumor size (8.4±3.0 cm versus 3.1±1.7 cm; P<.01).
Laparoscopic adrenalectomy may be appropriate for patients with a presumptive diagnosis of AM and abdominal or flank pain, large tumor size, and/or uncertain diagnosis after imaging. Outcomes and morbidity following LA for AM and other adrenal pathology appear comparable.
肾上腺髓质脂肪瘤(AM)是一种良性病变,很少需要进行肾上腺切除术。我们在一个大型单机构系列研究中调查了AM的手术适应症和手术结果。
对前瞻性收集的数据进行回顾性队列研究。在巴恩斯犹太医院普通外科接受肾上腺切除术的患者(≥16岁)按手术适应症(髓质脂肪瘤与其他病理类型)分组,并使用非参数检验进行比较(α<0.05)。
在402例行肾上腺切除术的患者中,有16例(4.0%)切除了髓质脂肪瘤。14例疑似AM的患者接受了肾上腺切除术,其中13例(93%)术后病理证实为AM。肾上腺切除术的适应症为腹痛或侧腹痛、肿瘤体积大(>8 cm)、影像学表现不典型和/或下腔静脉受压。3例疑似其他肾上腺病变的患者最终病理证实为AM。15例手术采用腹腔镜方式,1例21 cm病变采用开放手术。因AM接受腹腔镜肾上腺切除术的患者(n = 15)与因其他肾上腺病变接受手术的患者(n = 343)在年龄、性别、美国麻醉医师协会分级、既往腹部手术史、肿瘤侧别、手术时间、中转率、估计失血量、术中并发症、住院时间和30天发病率方面相似。然而,切除AM的患者体重指数较高(36.5±8.1 kg/m²对30.1±7.5 kg/m²;P<0.01),术前肿瘤体积较大(8.4±3.0 cm对3.1±1.7 cm;P<0.01)。
对于初步诊断为AM且有腹痛或侧腹痛、肿瘤体积大及影像学检查后诊断不明确的患者,腹腔镜肾上腺切除术可能是合适的。AM和其他肾上腺病变行腹腔镜肾上腺切除术后的结果和发病率似乎相当。